Gilead Sciences has announced $7.6 million in grants to 24 U.S.-based community organization in support of health equity in breast cancer.

Awarded through the Toward Health Equity (THE) Oncology Grant, the funding supports evidence-based interventions that address barriers to care and social determinants of health, including patient navigator training, cultural competency training, and services to address barriers such as lack of transportation. Recipients include Asociación Latina De Asistencia Y Prevención Del Cáncer De Mama, Association of Community Cancer Centers, and Coalition of Blacks Against Breast Cancer.

According to Gilead Sciences, due to social, environmental, and economic disparities, people of color are at increased risk of developing or dying from breast cancer.

“Gilead is committed to advancing health equity and supporting these vital patient advocacy organizations working to close gaps in breast cancer care,” said Deborah H. Telman, Gilead Sciences executive vice president of corporate affairs and general counsel. “We believe our Toward Health Equity Oncology Grant awards contribute important new understanding to advance and care for anyone living with breast cancer. We look forward to seeing their dynamic, innovative programs come to life.”

For a complete list of recipients, see the Gilead Sciences website.

(Photo credit: Getty Images/Anchiy)